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ORIGINAL ARTICLE
Isotopic estimates of sugar intake are related to chronic disease
risk factors but not obesity in an Alaska native (Yup’ik) study
population
SH Nash1,2, AR Kristal3, A Bersamin1,2, K Choy1, SE Hopkins1, KL Stanhope4,5, PJ Havel4,5, BB Boyer1 and DM O’Brien1,2
BACKGROUND/OBJECTIVES: Sugar intake may be causally associated with chronic disease risk, either directly or by contributing to
obesity. However, evidence from observational studies is mixed, in part due to the error and bias inherent in self-reported measures
of sugar intake. Objective biomarkers may clarify the relationship between sugar intake and chronic disease risk. We have recently
validated a biomarker of sugar intake in an Alaska Native (Yup’ik) study population that incorporates red blood cell carbon and
nitrogen isotope ratios in a predictive model. This study tested associations of isotopic estimates of sugar intake with body mass
index (BMI), waist circumference (WC) and a broad array of other physiological and biochemical measures of chronic disease risk in
Yup’ik people.
SUBJECTS/METHODS: In a cross-sectional sample of 1076 Yup’ik people, multiple linear regression was used to examine
associations of sugar intake with BMI, WC and other chronic disease risk factors.
RESULTS: Isotopic estimates of sugar intake were not associated with BMI (P¼ 0.50) or WC (P¼ 0.85). They were positively
associated with blood pressure, triglycerides (TG) and leptin, and are inversely associated with total-, high-density lipoprotein- and
low-density lipoprotein-cholesterol and adiponectin.
CONCLUSIONS: Isotopic estimates of sugar intake were not associated with obesity, but were adversely associated with other
chronic disease risk factors in this Yup’ik study population. This ﬁrst use of stable isotope markers of sugar intake may inﬂuence
recommendations for sugar intake by Yup’ik people; however, longitudinal studies are required to understand associations with
chronic disease incidence.
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INTRODUCTION
There has been considerable controversy over whether sugar
intake is causally associated with chronic disease risk,1 either
directly or by contributing to obesity. Intake of a high sugar diet is
associated with elevated plasma triglycerides (TG),2,3 and
consumption of high sugar snacks has been experimentally
linked with elevated glucose and insulin levels.4 Furthermore,
many studies have found that sugars (particularly fructose),5
consumed in beverage form (sugar-sweetened beverages; SSB)
are associated with type 2 diabetes and coronary heart disease
risk,6–8 as well as chronic disease risk factors including increased
body mass index (BMI) or body weight,9,10 visceral adiposity,9
dyslipidemia,8–10 elevated blood pressure,11 insulin resistance12
and markers of inﬂammation.8,13 However, other studies have
shown weak or no associations between either sugar or SSB intake
and chronic disease risk factors.14,15 All observational studies of
the association between sugar or SSB intake and chronic disease
risk factors have relied on self-reported measures of food intake,
which are subject to substantial error and bias.16 Therefore,
associations are likely attenuated, which may, in part, explain the
inconsistency of these ﬁndings.
A biomarker of sugar or SSB intake would strengthen
inferences from observational studies and help to resolve the
role of sugar intake in the development of chronic disease.
Measures of 24-h urinary sugars have recently been validated as
biomarkers of total and added sugars intake.17 However, these
measurements require multiple urine collections to reliably
estimate intake; therefore, they may be impractical to collect
for large study samples. Alternatively, we and others have shown
that naturally occurring variations in stable isotope ratios can be
used as objective measures of diet.18,19 Speciﬁcally, the carbon
stable isotope ratio (d13C) is elevated in corn- and cane sugar-
based sweeteners,20 and has been proposed as a low-burden,
economical and easy to measure indicator of usual sugar intake
in several US populations.18,21,22 We have recently validated an
improved isotopic model of sugar intake in an Alaska native
(Yup’ik) study population,19 which incorporates both the carbon
and nitrogen (d15N) isotope ratios. A model based on both d13C
and d15N is improved because d15N accounts for confounding
dietary effects on d13C. In this Yup’ik study population, the dual
isotope model explained 48% of the variability in reported total
sugar intake.
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The overall objective of this study was to use this dual isotope
model to investigate associations of sugar intake with measures of
obesity and chronic disease risk in Yup’ik people. In this study, we
were interested in sugar intake from both food and beverages;
therefore, we examined associations with isotopic estimates of
total sugar intake. Our study sample was a community-based,
cross-sectional sample of 1076 Yup’ik people. We were interested
in whether sugar intake was linked to obesity and other chronic
disease risk factors in this study population because their intake of
high sugar foods has increased substantially over the last several
decades,23 and the impact of this increase on Yupik people’s
health is unknown. Our aims were twofold. First, we investigated
associations of isotopic estimates of total sugar intake with
two measures of obesity: BMI and waist circumference (WC).
Our hypothesis was that sugar intake would be positively
associated with both BMI and WC. Second, we investigated
whether isotopic estimates of total sugar intake were associated
with biomarkers of chronic disease risk, independently of BMI. On
the basis of previous studies in other study populations, we
hypothesized that these measures of sugar intake would be
positively associated with blood pressure, fasting TG, total
cholesterol, C-reactive protein, fasting glucose and insulin
resistance. Determining whether sugar intake is associated with
obesity and other chronic disease risk factors may inﬂuence
dietary recommendations for Yup’ik people, and will provide
additional evidence toward our understanding of the role of sugar
intake in the etiology of obesity and related chronic diseases.
MATERIALS AND METHODS
Participant recruitment and procedures
Data are from the Center for Alaska Native Health Research (CANHR) study,
a cross-sectional, community-based participatory research study of the
nutritional, genetic and psychosocial factors affecting obesity and related
disease risk in the Yup’ik population. This study was approved by the
University of Alaska Fairbanks Institutional Review Board, the National and
Area Indian Health Service Institutional Review Boards and the Yukon–
Kuskokwim Health Corporation Human Studies Committee.
Between 2003 and 2012, a community-based sample of 1510
participants aged 14–94 was recruited from 10 communities in rural
Southwest Alaska, as described elsewhere.24 At entry into the study,
participants completed questionnaires to provide information on
demographics, medical history and smoking status (current: yes or no).
Biological samples and anthropometric measurements were also collected.
Study sample
For comparison of isotope-based estimates of total sugar intake with
measures of obesity and chronic disease risk factors, we excluded 341
participants aged o19 years, 87 participants with missing stable isotope
measurements and 6 participants with missing BMI measurements.
This left a study sample of n¼ 1076. However, because data were missing
for individual risk factors, the sample size for each analysis varied from 783
to 1039, with the exception of interleukin-6 (IL-6) and insulin-like growth
factor 1 (IGF-1), which were available only on a subset of the ﬁrst seven
communities enrolled in the study (n¼ 360 and 363, respectively). From
within these communities, samples were balanced across age and sex, as
described in detail elsewhere.25
Anthropometric and biochemical measurements
Anthropometric measurements, including height, weight and blood
pressure, were measured by trained staff using protocols from the
NHANES III Anthropometric Procedures Manual,26 as described by Boyer
et al.24 Blood samples were collected into ethylenediaminetetraacetic acid
(EDTA) tubes from participants after a minimum 8-h fast, and processed
locally: serum, lymphocyte and red blood cell (RBC) fractions were
separated using a portable centrifuge and stored at –15 1C. Within 6 days,
samples were shipped to the University of Alaska Fairbanks and stored at
 80 1C. Biomarkers of chronic disease risk, including TG, total cholesterol,
high-density lipoprotein (HDL) cholesterol (HDL), low-density lipoprotein
(LDL) cholesterol (LDL), adiponectin, blood glucose, HbA1c, insulin, leptin,
ghrelin, C-reactive protein (CRP), insulin-like growth factor I and IL-6, were
assayed in serum as previously described.24,25 Insulin resistance was
assessed using the homeostasis model of insulin resistance (HOMA-IR)
index: (fasting insulin (mU/ml) fasting glucose (mg/dl))/405.27
Stable isotope analysis
RBCs were pipetted into tin capsules, autoclaved and prepared for isotopic
analysis as previously described.28 Neither autoclaving nor the use of
ethylenediaminetetraacetic acid tubes affects RBC carbon or nitrogen
isotope ratios.29 Samples were analyzed at the Alaska Stable Isotope
Facility by continuous-ﬂow isotope ratio mass spectrometry, using a
Costech ECS4010 Elemental Analyzer (Costech Scientiﬁc Inc., Valencia, CA,
USA) interfaced to a Finnigan Delta Plus XP isotope ratio mass
spectrometer via the Conﬂo III interface (Thermo-Finnigan Inc., Bremen,
Germany). The conventional means of expressing natural abundance
isotope ratios is as delta values in permil (%) relative to international
standards as dX¼ (Rsample Rstandard)/(Rstandard) 1000%. Here, R is the
ratio of heavy to light isotope (15N/14N or 13C/12C). The standards are
Vienna PeeDee Belemnite for carbon and atmospheric nitrogen for
nitrogen. To assess analytical precision, an internal standard was
analyzed for every 10 samples (peptone: d15N: 7.0, d13C¼  15.8).
Precision was measured in two ways: as the s.d. and the coefﬁcient of
variation of these analyses. Accuracy was within 0.1%, and precision was
within 0.2% for both isotopes, and the coefﬁcient of variation for these
analyses was 3.3% for d15N and 0.6% for d13C. Because biological samples
from this study have a lower 13C/12C than Vienna PeeDee Belemnite, d13C
values are negative. The term ‘d13C values’ is hereafter abbreviated as d13C,
and the term ‘d15N values’ is abbreviated as d15N.
Estimating sugar intake using stable isotope ratios
Total sugar intake was estimated using a dual isotope model, which was
calibrated in a sample of 68 Yup’ik participants based on self-reported total
sugar intake from 4, weekly 24-h recalls:19
ln total sugar intakeð Þ¼ 13:07þ 0:33ðd13CÞ 0:23ðd15NÞ
This predictive equation explained 48% of the variation in self-reported
total sugar intake in the calibration data set. Although the calibration
population was drawn from two of the 10 Yup’ik communities participating
in the present study, it is possible that the calibration equation might differ
slightly for the larger population studied here. Furthermore, because our
isotopic model of total sugar intake was calibrated against self-reported
data, it may have incorporated reporting bias. For these reasons, we tested
whether our isotopic model of sugar intake was associated with a second,
unbiased marker of total sugar intake recently validated for Yup’ik people:
the carbon isotope ratio of RBC alanine (d13CALA).
30 We tested this
association by measuring d13CALA in a random sample of 50 research
participants from the present study. Our estimates of total sugar intake
calibrated from self-report were signiﬁcantly correlated with d13CALA
(Pearson’s r: 0.46), which gives us further conﬁdence that our estimate of
sugar intake is objective and valid for use in this study population.
Hereafter, total sugar intake estimated using this dual isotope model is
referred to as ‘sugar intake’.
Statistical analyses
We examined the associations of sugar intake with the following measures:
systolic blood pressure (SBP) diastolic blood pressure (DBP), TG, total
cholesterol, LDL, HDL, ghrelin, leptin, adiponectin, HbA1c, glucose, insulin,
HOMA-IR, insulin-like growth factor I, IL-6 and CRP. TG, leptin, insulin,
HOMA-IR, IL-6 and CRP were log-transformed for analysis. Outlying values
of chronic disease risk biomarkers (44 s.d. above the mean) were
excluded because they were judged to be physiologically unreasonable.
We excluded the following values: SBP (n¼ 2), TG (n¼ 7), total cholesterol
(n¼ 1), glucose (n¼ 4), HbA1c (n¼ 3), leptin (n¼ 1), insulin (n¼ 5), HOMA-
IR (n¼ 5), adiponectin (n¼ 1), CRP (n¼ 14) and IL-6 (n¼ 5). For IL-6, values
below the limit of detection (n¼ 95) were replaced by the limit of
detection divided by the square root of 2.31 Finally, participants taking
blood pressure (n¼ 142), cholesterol-lowering (n¼ 43) or diabetes (n¼ 12)
medications were excluded for analyses of associations with blood
pressure, lipids and glucose/HbA1c/insulin/HOMA-IR, respectively.
We assessed whether sugar intake differed by demographic and health
characteristics using one-way analysis of variance models. To determine
whether sugar intake and chronic disease risk factors were associated with
BMI or WC, we used age- and sex-adjusted multiple regression models.
Biomarkers of sugar detect chronic disease risk
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To determine whether sugar intake was associated with biomarkers of
chronic disease risk, we used BMI-adjusted multiple linear regression
models. In addition to BMI adjustment, models were also adjusted for age
(continuous), sex, current smoking status (yes or no) and year of data
collection. Control for chewing tobacco (iqmiq) and pulse did not affect the
results; therefore, these variables were not included in the models
presented. A smaller number of study participants had physical activity
(actiheart counts per day; n¼ 246)32 and self-reported dietary intake
information (n¼ 230).28 In these subsets, sugar intake was not associated
with reported total energy intake (b (95% conﬁdence interval, CI)¼ 0.92
( 1.09, 2.95), P¼ 0.37) but was positively associated with physical activity
(b (95% CI)¼ 190.3 (104.7, 275.8), Po0.0001). In this smaller subset,
estimated sugar intake was associated with DBP, TG, total cholesterol, HDL
and LDL only; however, the associations with these risk factors were not
affected by the adjustment for physical activity (data not shown).
Both linear and quadratic associations were assessed. We used a
conservative criterion (Po0.01) for reporting quadratic associations owing
to the likelihood that multiple contrasts would lead to chance associations.
We calculated the unadjusted P-value using a signiﬁcance level of 0.05, and
also indicated which tests remained statistically signiﬁcant after adjust-
ment using the Bonferroni–Holm method to account for multiple testing.33
All statistical analyses were performed using JMP version 8 (SAS Institute,
Cary, NC, USA) or STATA I/C version 12 (StataCorp. 2011, College Station,
TX, USA).
RESULTS
Table 1 gives associations of demographic and health-related
characteristics with sugar intake. The total study population
ranged in age from 19 to 94 years (mean¼ 42 years±15); 55%
were women and 68% were overweight or obese. Mean sugar
intake was 93 g/day, which is lower than has been reported for
other US populations using data from the National Health and
Nutrition Examination Survey.34,35 Sugar intake ranged from 24 to
217 g/day and was 7% higher in men, 22% higher in current
smokers and 95% higher in participants aged 19–40 years
compared with those aged 460 years.
After control for age and sex, neither BMI nor WC was
associated with sugar intake (Table 2). Table 2 also gives
associations of sugar intake with BMI and WC stratiﬁed by age
and sex. The only signiﬁcant association between sugar intake and
either measure of obesity was an inverse association with BMI in
participants over the age of 60 years.
Table 3 gives the linear associations of total sugar intake with
chronic disease risk factors. Independent of BMI, sugar intake was
positively associated with SBP, DBP, TG, leptin, and inversely
associated with HDL, LDL, total cholesterol and adiponectin. There
were marginally non-signiﬁcant positive associations with insulin
and HOMA-IR. The largest differences in chronic disease risk
factors were seen with leptin, adiponectin and HOMA-IR, which
were 13.8%, 13.0% and 6.7% higher in quartile 4 than quartile 1 of
estimated sugar intake, respectively. LDL, HDL and total choles-
terol were 11.3%, 9.6% and 7.6% lower in quartile 4 than quartile 1
of sugar intake, respectively. There were no associations of sugar
intake with ghrelin, glucose, HbA1c, insulin-like growth factor I,
CRP or IL-6. After the Bonferoni–Holm correction, the associations
with DBP, TG, total cholesterol, HDL, LDL and leptin remained
statistically signiﬁcant.
DISCUSSION
There were strong associations of isotopic estimates of sugar
intake with chronic disease risk factors in this cross-sectional
sample of Yup’ik people. Contrary to our original hypothesis, there
was no association of isotopic estimates of sugar intake with BMI
or WC. However, these estimates of sugar intake were associated
with increased blood pressure, TG, leptin and decreased HDL, LDL,
total cholesterol and adiponectin. These results suggest that,
although sugar intake is not directly associated with obesity in this
Yup’ik study population, it may be independently associated with
higher risk of developing chronic disease risk factors, including
hypertension and dyslipidemia.
The ﬁnding that isotopic estimates of sugar intake were not
associated with measures of obesity (BMI or WC) is consistent with
some observational studies;14,36 however, other studies have
demonstrated signiﬁcant and positive effects of either sugar or
SSB intake on BMI, body weight or risk of obesity.7 This association
is likely mediated, at least in part, by a higher energy intake.37
We were unable to assess the association between sugar and total
energy intake in the complete study sample; however, in a
substantially smaller subset of participants with self-reported
dietary data (n¼ 230), we found no association between our
measure of sugar intake and reported total energy intake. This
suggests that our ﬁndings were likely not confounded by total
energy intake, although this smaller sample size will have reduced
our power to detect an association with our marker of sugar.
However, this ﬁnding is consistent with a previous study by our
group that found no association between dietary patterns and
total energy intake.38 Furthermore, traditional food intake as
measured using d15N28 showed a marginal but positive
association with BMI (b (95% CI)¼ 0.35 (0.04, 0.66), P¼ 0.027);
therefore, the higher fat content of the marine-based traditional
Yup’ik diet38 coupled with the negative relationship between
intake of sugar and traditional foods30 may have obscured any
potential positive relationship between sugar intake and BMI or
WC.
Sugar intake showed a marginally non-signiﬁcant positive
association with insulin and HOMA-IR, and was not associated
with glucose or HbA1c. The results of other observational studies
that examine associations of sugar or SSB intake with indicators of
glucose tolerance or insulin resistance have been inconsis-
tent.8,12,39–41 Determining whether sugar intake is associated
with glucose, HbA1c, insulin and HOMA-IR is of particular
relevance to the health of Yup’ik people, because, although
diabetes prevalence is low (2010: 27/1000), it increased 38%
between 1990 and 2004,42 and recent studies have suggested a
positive relationship between sugar intake and type 2 diabetes.6,43
Larger, longitudinal studies are needed to clarify the association of
sugar intake with insulin and HOMA-IR in Yup’ik people, and to
address whether sugar intake will lead to the development of
hyperglycemia or insulin resistance over time.
Sugar intake was positively associated with both SBP and DBP
independently of BMI and current smoking status, a ﬁnding that is
consistent with several other observational studies.11,39,40
Proposed mechanisms for this relationship include changes to
the uric acid pathway induced by fructose consumption44 or
Table 1. Associations of demographic and health-related
characteristics with sugar intake
n (%) Sugar intakea,b g/day P
Total study population 1076 (100) 95.3 (93.1, 97.5)
Sex 0.0017
M 499 (46) 99.1 (95.8, 102.4)
F 577 (54) 92.0 (89.1, 94.9)
Age o0.0001
19 to o40 years 549 (51) 112.5 (109.7, 115.2)
40 to o60 years 375 (35) 85.3 (82.0, 88.7)
460 years 152 (14) 57.9 (54.3, 61.6)
Smokers o0.0001
Current 333 (31) 108.9 (105.1, 112.8)
Non smoker 722 (67) 88.6 (86.0, 91.2)
BMI 0.0004
o25 kg/m2 384 (36) 100.9 (97.4, 104.5)
25 to o30 kg/m2 354 (33) 94.0 (90.1, 97.9)
430 kg/m2 338 (31) 90.3 (86.2, 94.3)
Abbreviations: BMI, body mass index; CI, confidence interval. aMean (95%
CI). bSugar intake was estimated using the formula: ln(sugar intake)¼ 13.07
þ 0.33(d13C) 0.23(d15N).19
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increased sodium retention.45 Although our ﬁndings are not
informative regarding the mechanism by which this association
may occur, they are suggestive that decreased sugar intake may
be beneﬁcial for the blood pressure of Yup’ik people.
Moreover in agreement with ﬁndings from several prospective
studies8,39,40 was the strong positive association of sugar intake
with TG. This association may be due to high intake of fructose
(either directly, or as high fructose corn syrup or sucrose),9 which
is known to increase TG levels through increased hepatic de novo
lipogenesis2,3,9 and decreased rate of peripheral TG clearance.2
Alternatively, sugar intake is positively associated with intake of
carbohydrates in this population,45 which may also lead to
increased triglyceride levels.46 We also found a strong inverse
association of sugar intake with HDL, LDL and total cholesterol,
which was in agreement with previous ﬁndings for HDL,8,39
but counter to our expectations for LDL and total cholesterol.10
Here, because of the high intakes of eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA) from the Yup’ik traditional diet,38
HDL is high and positively associated with total cholesterol
(b (95% CI)¼ 1.12 (0.98, 1.27), Po0.0001. HDL is also associated
with LDL in this population (b (95% CI)¼ 0.31 (0.18, 0.44),
Po0.0001), possibly due to other high-fat components of the
traditional diet.47 Thus, this phenomenon may be due to the
unique dietary patterns of this Yup’ik people and these ﬁndings
may not be applicable to other study populations.
We found that sugar intake was not associated with C-reactive
protein in this Yup’ik study population, which contrasts with the
positive associations reported by the few studies that examined
Table 2. Associations of sugar intake with BMI and waist circumference, stratified by age category and sexa,b
n BMI, kg/m2 Waist circumference, cm
Mean±s.e. BMI 430, % bc (95% CI) P Mean±s.e. bc (95% CI) P
Total 1076 28.1±0.2 31  0.09 ( 0.37, 0.18) 0.50 92.0±0.4 0.07 ( 0.63, 0.77) 0.85
Age
19 to o40 years 549 27.7±0.3 28  0.30 ( 0.67, 0.07) 0.12 89.5±0.6  0.67 ( 1.60, 0.26) 0.16
40 to o60 years 375 28.3±0.3 34 0.19 ( 0.23, 0.60) 0.37 93.2±0.7 0.44 ( 0.64, 1.51) 0.43
460 years 152 29.0±0.5 38  1.38 ( 2.44,  0.32) 0.011 98.0±1.3  2.42 ( 5.34, 0.49) 0.10
Sex
M 499 26.5±0.2 19  0.00 ( 0.30, 0.31) 0.96 91.5±0.6 0.24 ( 0.71, 1.10) 0.67
F 577 29.5±0.3 42  0.20 ( 0.65, 0.27) 0.39 92.5±0.6 0.23 ( 1.14, 1.00) 0.90
Abbreviations: BMI, body mass index; CI, confidence interval; F, female; M, male; WC, waist circumference. aAssociations in the complete study sample are age
and sex adjusted. Associations within age and sex strata are sex and age adjusted, respectively. bSugar intake was estimated using the formula: ln(sugar
intake)¼ 13.07þ 0.33(d13C) 0.23(d15N).19 cSlopes are interpreted as change in obesity measure (BMI or WC) for each 25 g increase in total sugar intake.
Table 3. Linear associations of sugar intake with chronic disease risk factors, and means of those risk factors stratified by quartile of sugar intake
(n¼ 380–1039)a
n Sugar intakeb,c (range, g/day) bd (95% CI) P
Quartile 1 (23 to
o66)
Quartile 2 (66 to
o93)
Quartile 3 (93 to
o121)
Quartile 4 (121
to o217)
SBP, mmHg 879 116.7±1.0 118.4±0.8 117.7±0.8 120.2±0.8 0.78 (0.14, 1.43) 0.018
DBP, mmHg 881 68.6±0.8 70.7±0.6 70.8±0.6 71.5±0.7 0.88 (0.39, 1.37) o0.0001e
Triglycerides, mg/dlf 911 66.0 (62.4, 69.8) 74.8 (71.3, 78.5) 81.0 (77.1, 85.0) 81.9 (77.6, 86.4) 6.09 (3.98, 8.20) o0.0001e
Cholesterol, mg/dl 921 226.3±3.3 229.8±2.6 215.6±2.6 208.6±2.9  5.09 ( 7.21,  2.97) o0.0001e
HDL, mg/dl 919 65.8±1.1 64.9±1.0 61.0±1.1 59.7±1.1  1.62 ( 2.42,  0.82) o0.0001e
LDL, mg/dl 921 148.5±2.6 148.4±2.2 138.7±2.3 130.6±2.5  5.08 ( 7.21,  2.97) o0.0001e
Leptin, ng/mlf 810 6.8 (6.3, 7.4) 6.9 (6.4, 7.4) 7.0 (6.5, 7.5) 7.4 (6.8, 8.0) 4.44 (1.43, 7.53) 0.004e
Adiponectin, mg/ml 959 10.4±0.4 9.7±0.3 9.6±0.3 9.5±0.3  0.32 ( 0.57,  0.06) 0.015
Ghrelin, pg/ml 809 424.1±11.1 424.2±10.0 411.6±10.8 404.5±11.8  0.65 ( 9.11, 7.81) 0.88
HbA1c, % 960 5.6±0.02 5.5±0.02 5.5±0.02 5.5±0.02  0.02 ( 0.03, 0.00) 0.09
Glucose, mg/dl 1038 94.2±0.7 93.0±0.6 92.3±0.6 92.9±0.6  0.03 ( 0.51, 0.44) 0.90
Insulin, mU/dlf 787 12.2 (11.4, 13.0) 12.0 (11.4, 12.8) 12.6 (11.8, 13.4) 12.6 (11.8, 13.5) 2.29 ( 0.14, 4.78) 0.069
HOMA IRf 782 2.8 (2.6, 3.0) 2.7 (2.5, 2.9) 2.9 (2.7, 3.1) 2.9 (2.7, 3.1) 2.42 ( 0.18, 5.11) 0.064
IGF-I, ng/ml 386 272.8±9.5 246.3±8.7 250.9±8.5 248.0±9.2  3.53 ( 10.34, 3.28) 0.31
CRP, mg/dlf 782 0.08 (0.07, 0.10) 0.11 (0.09, 0.13) 0.10 (0.08, 0.12) 0.13 (0.10, 0.15) 5.91 ( 0.97, 13.3) 0.094
IL-6, mg/lf 379 0.08 (0.06, 0.13) 0.10 (0.07, 0.12) 0.09 (0.07, 0.12) 0.09 (0.07, 0.12) 3.94 ( 6.03, 15.0) 0.45
Abbreviations: BMI, body mass index; CI, confidence interval; CRP, C-reactive protein; DBP, diastolic blood pressure; HOMA-IR, homeostasis model of insulin
resistance; IGF-I, insulin-like growth factor I; IL-6, interleukin-6; SBP, systolic blood pressure. aSample size varies because of outliers and missing data. Multiple
linear regression models were adjusted for age (continuous), sex, BMI (continuous), smoking status (yes or no) and year of data collection. bSugar intake was
estimated using the formula: ln(sugar intake)¼ 13.07þ 0.33(d13C) 0.23(d15N).19 cMeans of chronic disease risk biomarkers by quartile of sugar intake are least
squares means (±s.e.), adjusted for age (continuous), sex, BMI (continuous) and smoking status (yes or no). Geometric means (95% CI) are given for log-
transformed variables. dSlopes are interpreted as change in chronic disease risk factor for each 25 g increase in total sugar intake. eAssociations remained
statistically significant after the Bonferroni–Holm correction. fLog-transformed values were used for regression analyses; slopes have been back transformed
for ease of interpretation and are interpreted as percentage change in the chronic disease risk factor for each 25 g increase in sugar intake.
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sugar or SSB intake and inﬂammation.8,10,13 Again, this ﬁnding
may be related to the overall high intakes of EPA and DHA in the
Yup’ik population.38 EPA and DHA promote an anti-inﬂammatory
state,48 and were inversely associated with CRP in a subset of this
study population.25 Therefore, the lack of association may be due
to the unique dietary patterns of this study population and may
not be relevant to other US populations.
Our ﬁndings that high sugar intake was associated with higher
levels of circulating leptin and lower levels of adiponectin are also
in contrast to those from other observational studies, which have
demonstrated an inverse8 or no10,49 association of reported sugar
intake with leptin and no association with adiponectin.8,49
However, one experimental study has demonstrated decreased
adiponectin following 10 weeks of sugar consumption.50 Higher
leptin and lower adiponectin levels may lead to increased risk of
cardiovascular disease, renal disease51 and type 2 diabetes;47
therefore, our results suggest that high sugar intake may adversely
affect chronic disease risk in Yup’ik people. These results remained
statistically signiﬁcant when adjusted for either BMI or WC,
measures of adiposity that are known to affect these adipokines.
Finally, we note that some of the associations presented here,
particularly those with blood lipids, are the inverse of those found
with biomarkers of EPA and DHA intake in a subset of this study
population.38 Thus, these relationships could partially reﬂect the
strong inverse association between intakes of sugar and
traditional foods,30 which are high in EPA and DHA. We tested
whether adjustment for RBC EPA and DHA affected associations
between sugar intake and chronic disease risk factors in a subset
of this study population (n¼ 279–361).25 In this substantially
smaller study sample, associations of sugar intake with SBP, DBP,
adiponectin, insulin and HOMA-IR were statistically insigniﬁcant.
Associations of sugar intake with total cholesterol, LDL and leptin
were weakened, but remained statistically signiﬁcant after an
adjustment for RBC EPA or DHA. However, associations with TG
and HDL became non-signiﬁcant after EPA or DHA adjustment.
These ﬁndings suggest that sugar intake does affect blood lipids
and leptin, independent of EPA and DHA intake, in this study
population. We suggest that longitudinal studies are warranted to
disentangle the effects of sugar and traditional food intake on
chronic disease risk in Yup’ik people.
The primary strength of this study is that it uses biomarker-
based estimates of sugar intake to examine associations with
chronic disease risk in a large sample of Yup’ik people. Although
stable isotope ratios have shown potential as biomarkers of sugar
intake in several other non-Native US populations,18,21,22 this is the
ﬁrst study to use these markers to evaluate associations with
chronic disease risk. These biomarker-based estimates were likely
less biased than self-reported measures, and were available on a
much large number of study participants than would have been
available had we assessed diet using self-report. This study is also
one of very few that examine the association of non-traditional
food intake and chronic disease risk in Yup’ik people.52
The primary limitation of this study is that it is based on a cross-
sectional study sample; therefore, we cannot exclude the
possibility of reverse causality, or residual confounding from
intake of other dietary components or lifestyle factors.
Furthermore, a limitation of isotopic biomarkers of sugar intake,
more generally, is that they cannot indicate intake of sugars that
are not 13C enriched, such as beet sugar and honey. Consumption
of these sugars was likely low in our Yup’ik study population, due
to restricted access to commercial foods in rural Yup’ik
communities;30 therefore, we expect the impact of this
limitation on this study to be minimal.
This study is the ﬁrst examination of the effects of sugar intake
on Yup’ik health, and used an objective biomarker of sugar intake
that was developed speciﬁcally for use with Yup’ik people.
We found that isotopic estimates of sugar intake was not
associated with BMI or WC in this Yup’ik study population, but
that it was positively associated with blood pressure, TG, insulin,
insulin resistance and leptin, and inversely associated with HDL,
LDL, total cholesterol and adiponectin. These ﬁndings suggest
that, although sugar intake is not associated with obesity in the
Yup’ik population, high intakes of sugar may have adverse effects
on chronic disease risk factors often related to obesity. Long-
itudinal studies are warranted to conﬁrm the ﬁndings of this study
and better understand associations of sugar intake with disease
risk in the Yup’ik population.
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